Merger Acquisitions Company's history involves acquisitions by major pharmaceutical companies like Shire and Takeda, indicating potential collaboration opportunities with these entities for mutual sales benefits.

Clinical Trials Expansion Baxalta has a track record of launching multiple clinical trials, showcasing a commitment to research and development. Partnering with Baxalta on ongoing or future trials could lead to new sales channels.

Innovative Product Launches The introduction of products like CUVITRU demonstrates a focus on innovation. Exploring partnerships around such cutting-edge offerings may open doors to new sales opportunities in niche markets.

Legal Battles and Partnerships Baxalta's involvement in patent disputes and collaborations with companies like Nektar presents insights into the company's strategy. Identifying synergies in areas of legal battles or partnerships could drive sales growth.

Investments in Assets The investment in assets like the AAV8 vector showcases the company's strategic direction towards specific technologies. Leveraging these assets in partnerships or licensing deals could lead to revenue growth.